Related Experiment Videos

Benefits and risks of calcium resonium therapy in hyperkalaemic preterm infants

T Grammatikopoulos1, A Greenough, C Pallidis

  • 1Department of Child Health, King's College Hospital, London, UK.

Insights

Rectal administration of calcium resonium resin in premature infants is not evidence-based and carries significant risks. Glucose and insulin infusions are more effective and safer alternatives for managing hyperkalemia in neonates.

Area of Science:

  • Neonatal Medicine
  • Pediatric Gastroenterology
  • Clinical Pharmacology

Background:

  • Hyperkalemia is a critical concern in premature infants, often managed with medications like calcium resonium resin.
  • The use of exchange resins in neonatal care lacks robust evidence, prompting a review of current practices.

Observation:

  • An intestinal perforation occurred in a premature infant after rectal administration of calcium resonium resin.
  • Literature review revealed anecdotal evidence supporting resin use but a lack of high-quality trials in preterm infants.

Findings:

  • The only randomized trial in premature infants showed resins were less effective than glucose and insulin infusions for hyperkalemia.
  • Reported side effects of resins include colonic necrosis, impaction, and perforation, particularly concerning in neonates.

Implications:

  • The current evidence does not support the routine use of exchange resins in premature infants.
  • Further randomized trials are needed to definitively assess the risks and benefits of exchange resins in this vulnerable population.
Abstract

Related Concept Videos